Pune vaccine to help Africa combat meningitis menace
An indigenous vaccine will help rid Africa of meningitis, one of the continent’s worst enemies.
Pharma
Sale of obesity drug banned in India
The sale of anti-obesity medicine Sibutramine has been banned in India due to rising instances of heart attacks among its users, the Drugs Controller General of India (DCGI) revealed.
Global polio eradication initiative may save US $40-50 billion
The global initiative to eradicate polio could provide net benefits of at least US $40-50 billion if transmission of wild polioviruses is interrupted within the next five years, according to a new study.
Sun Pharma receives USFDA nod for generic Clarinex, Tiazac
The Mumbai-based firm has received approval from US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) to market a generic version of Schering Plough’s Clarinex tablets, Sun Pharma said in a statement.
DCGI drafts rules on third-generation antibiotics
Even as the health ministry drags its feet over a national antibiotic policy, the Central Drugs Standard Control Organisation has prepared draft notifications that will regulate antibiotic drugs and the treatment of infectious diseases.
Lupin gets FDA nod for anti-allergic tablets
Drug firm Lupin announced it has been granted final approval by the United states Food and Drug Administration (USFDA) for antihistamine Desloratadine tablets, used for treating allergies.
Dr Reddy
Dr Reddy
Biocon in drug marketing deal with Pfizer
The world’s top drug maker Pfizer said that it has entered into a deal to sell drug maker Biocon Ltd’s biosimilar versions of diabetes treatment insulin.
Dr Reddy
Dr Reddy
US FDA nod to Zydus Cadila to sale anti BP drug
Drug firm Cadila Healthcare has got approval from US health regulator to market high blood pressure treatment tablets, Losartan Potassium and Losartan Potassium and HCTZ in the American market, reports media.
Piramal in a move to reabsorb Piramal Life Sciences
Piramal Healthcare, the renowned drug maker, is planning to merge its research and development (R&D) company Piramal Life Sciences back with itself, reports media. A possibility of merging Piramal Life Sciences back to the company was discussed earlier, but any final decision on this have not been taken so far, informed sources closed to the management.
Sun gets USFDA nod for generic heart disease drug
Drug maker Sun Pharma recently said it has received a tentative approval from US health regulator to sell a generic version of Crestor tablets, used in the treatment of various heart diseases, in the American market.
Aurigene and Pcovery in pact to undertake anti-fungal drug discovery
Aurigene Discovery Technologies Ltd, a collaborative drug discovery company with a proven track record of successful partnerships with about 10 collaborators globally, has announced a drug discovery deal with Danish start-up Pcovery, which designs and develops original drugs and agrochemicals.
